| 9751850 |
TRPA1 antagonists |
Richard J. Perner, Michael E. Kort, Jun Chen, Anil Vasudevan |
2017-09-05 |
$217,104,000 |
| 9108905 |
TRPA1 antagonists |
Richard J. Perner, Michael E. Kort, Jun Chen, Anil Vasudevan |
2015-08-18 |
$113,635,000 |
| 8877784 |
TRPA1 antagonists |
Richard J. Perner, Michael E. Kort, Jun Chen, Anil Vasudevan |
2014-11-04 |
$112,858,000 |
| 8691865 |
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers |
Xenia B. Searle, Ming C. Yeung, Andrew O. Stewart, Daria Darczak, Michael R. Schrimpf +1 more |
2014-04-08 |
$56,269,000 |
| 8609692 |
TRPV1 antagonists |
Arthur Gomtsyan, Erol K. Bayburt, Jun Chen, Jerome F. Daanen, Michael E. Kort +5 more |
2013-12-17 |
$84,666,000 |
| 8604053 |
TRPV1 antagonists |
Arthur Gomtsyan, Eric A. Voight, Erol K. Bayburt, Jun Chen, Jerome F. Daanen +5 more |
2013-12-10 |
$237,163,000 |
| 8247413 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Irene Drizin, Arthur Gomtsyan, John R. Koenig +5 more |
2012-08-21 |
$36,229,000 |
| 8129417 |
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers |
Andrew O. Stewart, Xenia B. Searle, Daria Darczak, Ming C. Yeung |
2012-03-06 |
$40,404,000 |
| 7998993 |
TRPV1 antagonists |
Richard J. Perner, John R. Koenig, Erol K. Bayburt, Jerome F. Daanen, Arthur Gomtsyan +5 more |
2011-08-16 |
$18,160,000 |
| 7335678 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Irene Drizin, Arthur Gomtsyan, John R. Koenig +5 more |
2008-02-26 |
$52,480,000 |
| 7074805 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Irene Drizin, Arthur Gomtsyan, John R. Koenig +5 more |
2006-07-11 |
$83,073,000 |
| 6933311 |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Chih-Hung Lee, Erol K. Bayburt, Irene Drizin, Arthur Gomtsyan, John R. Koenig +5 more |
2005-08-23 |
$125,490,000 |
| 6831193 |
Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors |
Chih-Hung Lee, Richard J. Perner, Daniel P. Larson, John R. Koenig, Arthur Gomtsyan +3 more |
2004-12-14 |
$66,667,000 |
| 4963568 |
Dopamine agonists |
Robert W. Schoenleber, John W. Kebabian, Yvonne C. Martin, Michael P. DeNinno, Richard J. Perner +6 more |
1990-10-16 |
$28,538,000 |
